Kamaljit Kaur

Tenecteplase versus alteplase for management of acute ischaemic stroke (NOR-TEST): a phase 3, randomised, open-label, blinded endpoint trial

Nicola Logallo, Vojtěch Novotný, Christopher Elnan Kvistad et al. · The Lancet Neurology · 2017 · 458 citations

Thrombosis, Endpoint Trial, Tenecteplase Versus Alteplase +13

Optimization and characterization of biomolecule immobilization on silicon substrates using (3-aminopropyl)triethoxysilane (APTES) and glutaraldehyde linker

Naga Siva Kumar Gunda, Minashree Singh, Lana Norman et al. · Applied Surface Science · 2014 · 326 citations

Biofunctional Material, Engineering, Glutaraldehyde Linker +6

Upregulation of mortalin/mthsp70/Grp75 contributes to human carcinogenesis

Renu Wadhwa, Syuichi Takano, Kamaljit Kaur et al. · International Journal of Cancer · 2006 · 239 citations

Green Synthesis: An Eco-friendly Route for the Synthesis of Iron Oxide Nanoparticles

Priya, Naveen, Kamaljit Kaur et al. · Frontiers in Nanotechnology · 2021 · 238 citations · Full text

Nanoparticles, Engineering, Iron Oxide Nanoparticles +17

Selective Killing of Cancer Cells by Leaf Extract of Ashwagandha: Identification of a Tumor-Inhibitory Factor and the First Molecular Insights to Its Effect

Nashi Widodo, Kamaljit Kaur, Bhupal Govinda Shrestha et al. · Clinical Cancer Research · 2007 · 189 citations · Full text